Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
about
Prognostic importance of defibrillator shocks in patients with heart failureOptimal programming management of ventricular tachycardia storm in ICD patientsAntitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary pr[Inappropriate ICD therapies: All problems solved with MADIT-RIT?].Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis.The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortalityDesign of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279].Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).Programming ICDs in the Modern Era beyond Out-of-the Box Settings.Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.Health economic concerns on cardiac rhythm management devices longevity and how to overcome them.Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy.QRS as a Risk Stratification Tool: Putting the Fragments Together.Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients.Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization.Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal StudyThe Difference on Features of Fragmented QRS Complex and Influences on Mortality in Patients with Acute Coronary Syndrome.Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy.Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis.Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.Delayed defibrillation testing after CRT-D implant-weighing competing risks.The nature of the game.Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design.Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: A cost-effectiveness study
P2860
Q24631203-5BE5763F-EDDC-4DA6-9324-33A6166A6BA1Q26853104-6DFD581E-4D52-45F1-81A6-B6C3BD71C65BQ33154124-E3354224-7D67-45F1-B2B8-AF5D700AA5B3Q33157547-B77B14F7-4EA6-4287-AA64-4E2892437B14Q33165644-940E92C9-A844-45EC-95C6-05E6B872D4E0Q33167254-6FD4F7E0-5D7F-467B-B969-2E6B113D7909Q33403639-EC9B2D9C-0E48-4065-922B-7D715AA3C145Q34402971-7EFA0B74-53A2-4F30-94AE-C3C701FDCDEFQ34881384-0F69261E-79C3-4FC2-96FC-54035AE1B947Q37140509-02AD28C6-D93B-4612-A476-E400DE43C5C8Q37837975-9F0BA0E3-7169-4919-A647-0DB1BBBC7628Q38411076-8C1F64C9-3E1C-4195-8B73-497992DF527FQ38428437-C7F28287-A4D4-428B-B85B-697B1E7A6B29Q38700354-B9DFA4C5-5282-419D-83EE-60913FC295D7Q41764473-235B0ABE-3236-4F81-B513-DD1A533B021CQ41846591-7FD85CA2-B35D-41E1-B4F2-BC4B327DE8F7Q44474787-EBE483D4-2AA3-4BFF-8627-C762DBE65499Q46195983-D1568009-30ED-4564-B86C-44A29191873BQ46770414-6750741C-B752-456E-97C0-612DA45E4CADQ47110013-345ECB3A-02B8-4FBA-B089-CDC5A636667EQ48293650-2B1FA275-6713-4279-932C-9B02DF392EE7Q50767884-5D2D44F3-D974-4158-AF81-89BB7251E9DAQ50855249-0BD7CB92-2206-4795-B321-B8506507F0A3Q51206884-C7FE03D2-E59C-463B-820C-83D17370178FQ51291032-65756F96-B813-4CBB-BBBB-4354814D60CCQ51475916-2E423E6F-1689-4CDE-BAF5-FA944E04D29EQ51558588-2D0B8772-B4B3-461E-9A0B-A4D3033C50EBQ53429962-16D6608C-BE0B-4C7C-B3F5-BEC7407C293AQ57446615-25E3E251-42D8-4ADC-9CA2-CD5319F53BD6
P2860
Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Differences in tachyarrhythmia ...... chronization therapy patients.
@ast
Differences in tachyarrhythmia ...... chronization therapy patients.
@en
type
label
Differences in tachyarrhythmia ...... chronization therapy patients.
@ast
Differences in tachyarrhythmia ...... chronization therapy patients.
@en
prefLabel
Differences in tachyarrhythmia ...... chronization therapy patients.
@ast
Differences in tachyarrhythmia ...... chronization therapy patients.
@en
P2093
P2860
P1476
Differences in tachyarrhythmia ...... chronization therapy patients.
@en
P2093
Bruce L Wilkoff
James Young
William T Abraham
P2860
P304
P356
10.1046/J.1540-8167.2004.03625.X
P577
2004-09-01T00:00:00Z